Facebook
  1. Home
  2. Solutions
  3. Symphony Health Conference Posters

Conference Posters

Immuno-Oncology-co-therapies

AMCP 2024

In recent years, the number of prescriptions requiring prior authorisation (PA) has continued to grow at a significant rate. Pharmacy prescription rejections for PA may result in the delay of therapeutic treatment, which may also disproportionately impact certain patient populations when looking at select social determinants of health.

We recently presented a poster at the AMCP Conference in New Orleans which discussed quantifying the impact of social determinants of health on patient treatment and disease management within the diabetes market. 

14202 - 011 Blog - SDoH_1440x750 – 2

PMSA 2024

Up to 80% of health outcomes are directly associated with social and environmental factors. Read the latest research from Symphony Health, an ICONplc company; and Healthwise Data on evaluating how aspects of Social Determinants of Health (SDOH) impact patients’ persistence to prescribed diabetic treatments through a driver’s analysis using unsupervised machine learning.

ISPOR

Diabesity_obesity_diabetes_blog thumbnail

#1

Read the latest research from Symphony Health, an ICONplc company, on a study that assesses the adherence and discontinuation of GLP-1 receptor agonists and SGLT-2 inhibitors among adult patients with T2D in the United States based on real-world claims and linked clinical data from ICON’s Symphony Health Integrated Dataverse (IDV®).

vaccine-syringe

#2

Since the first approval of recombinant human growth hormone (HGH) in 1987, HGH has been the mainstay of treatment for patients diagnosed with growth hormone deficiency (GHD), Prader-Willi syndrome, Turner syndrome, and others. Read the latest research from Symphony Health, an ICONplc company; on evaluating the impact of HGH drug shortages on patient treatment switching patterns using real-world data.

blood_cells_002

#3

Myelofibrosis (MF) is a rare type of hematologic malignancy that affects healthy blood cell production and causes progressive fibrosis in the bone marrow Read the latest research from Symphony Health, an ICONplc company; on evaluating the impact of anemia and blood transfusions on patient treatment selection and survival rates for patients with Myelofibrosis (MF) using real-world data

Get all posters

Download all posters from AMCP 2024, OMSA 2024 and ISPOR.

In this section

Connect with us